Search Results 581-590 of 16942 for pharmacogenetics
Charles J. Bruce, M.B., Ch.B., a Mayo Clinic cardiologist, develops technologies that expand how cardiovascular care is delivered.
The purpose of this study is to learn more about arteriovenous malformation (AVM), a type of blood vessel abnormality in the brain. Participation eligibility.
The Epigenetic Etiology of Human Disease Laboratory at Mayo Clinic is studying epigenetic mutations at the epigenome and transcriptome levels.
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The primary purpose of this study is to identify which aspects of treatment are most prevalent and burdensome to patients with advanced heart failure.
The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...
Mayo Clinic to sequence 100K participants to build genomic database for improved care and research in · Genetic testing provides insights to sudden unexplained ...
Cells with increased oncogene activity adopt a secretory phenotype. For example, increased levels of c-Src not only inhibit differentiation but also induce ...
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...
About this study. RATIONALE: Lymphadenectomy may remove tumor cells that have spread to nearby lymph nodes in patients with invasive bladder cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.